A5102168962- Cervical Cancer and HPV Research
- RNA modifications and cancer
- Statistical Methods in Clinical Trials
- Cutaneous Melanoma Detection and Management
- Ocular Oncology and Treatments
- Ovarian cancer diagnosis and treatment
- Colorectal Cancer Treatments and Studies
- Economic and Financial Impacts of Cancer
- Molecular Biology Techniques and Applications
- Nonmelanoma Skin Cancer Studies
- RNA Research and Splicing
- Dermatology and Skin Diseases
- Psoriasis: Treatment and Pathogenesis
- Allergic Rhinitis and Sensitization
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Endometrial and Cervical Cancer Treatments
- Health Systems, Economic Evaluations, Quality of Life
National Cheng Kung University Hospital
2024-2025
National Cheng Kung University
2024
Chang Gung University
2017
Linkou Chang Gung Memorial Hospital
2010
This study aimed to estimate the costs associated with adverse events (AEs) in advanced lung cancer patients treated first-line therapies.
Abstract Introduction: The global yearly incidence and mortality of cervical cancer are 471,000 annual new cases 233,000 deaths. Almost 80% occur in less developed countries, where it accounts for 15% women. Cervical carcinoma ranks as the leading malignancy genital tract developing countries. recurrence indicate poor prognosis while clinicopathological risk factors exist. In order to identify potential molecular biomarker, proteomic analysis was performed gesolin protein selected. Materials...